 |
dexrazoxane |
|---|---|
| Trade Name | Totect(R) |
| Orphan Indication | Anthracycline extravasation during chemotherapy |
| USA Market Approval | USA |
| USA Designation Date | 2004-03-25 00:00:00 |
| Sponsor | Clinigen Healthcare Ltd.;Pitcairn House, First Avenue, Burton on Trent;Staffordshire |
